Sanofi-Aventis Signs MOU With Korean Health Ministry To Invest $55 Million In R&D
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Sanofi-Aventis signed a memorandum of understanding with the Korean government to invest a total of KRW 70 billion ($55.4 million) in research and development over the next five years
You may also be interested in...
Sanofi Looks To Build Stronger Alliances To Fuel R&D In Korea
Marking the conclusion of a 2009 MOU, Sanofi signed a letter of intent with the Korean government to take R&D investments to a new level.
Novartis Signs MOU To Invest $100 Million In R&D, Exchanges With Korean Scientists By 2013
SEOUL - Novartis signed a memorandum of understanding with Korea's Ministry for Health, Welfare and Family Affairs to invest $100 million (KRW 125 billion) over the next five years in the research and development of new drugs, scientific exchanges and collaboration in the life sciences
Novartis Signs MOU To Invest $100 Million In R&D, Exchanges With Korean Scientists By 2013
SEOUL - Novartis signed a memorandum of understanding with Korea's Ministry for Health, Welfare and Family Affairs to invest $100 million (KRW 125 billion) over the next five years in the research and development of new drugs, scientific exchanges and collaboration in the life sciences